Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Carswell, 1975, An endotoxin-induced serum factor that causes necrosis of tumors, 72, 3666
Currie, 1975, Activated macrophages release a factor which lyses malignant cells but not normal cells, J Exp Med, 142, 1600, 10.1084/jem.142.6.1600
Fisch, 1983, In vitro production of rabbit macrophage tumor cell cytotoxin, Int J Cancer, 32, 105, 10.1002/ijc.2910320117
Green, 1977, Corynebacterium parvum as the priming agent in the production of Tumor Necrosis Factor in the mice, J Natl Cancer Inst, 59, 1519, 10.1093/jnci/59.5.1519
Ishii, 1976, Inhibition of tumor growth in vivo and in vitro by macrophages from rats treated with a streptococcal preparation, OK-432, Gann, 67, 115
Hojo, 1981, Cytotoxic cells induced in tumor-bearing rats by a streptococcus preparation (OK-432), Gann, 72, 692
Kawaguchi, 1983, Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK-432, Immunopharmacology, 6, 177, 10.1016/0162-3109(83)90019-X
Kimura, 1976, Immunochemotherapy in human lung cancer using the streptococcal agent OK-432, Cancer, 37, 2201, 10.1002/1097-0142(197605)37:5<2201::AID-CNCR2820370507>3.0.CO;2-Q
Kondo, 1975, Streptococcal as an activator of host-mediated immune response: Cellular immunity and alternate pathway of complement, Gann, 66, 675
Matthews, 1978, Tumor-necrosis factor from the rabbits. II. Production by monocyte, Brit J Cancer, 38, 310, 10.1038/bjc.1978.203
Matthews, 1981, Tumor necrosis factor from the rabbits. V. Synthesis from various tissues of normal and BCG-infected rabbits, Brit J Cancer, 44, 418, 10.1038/bjc.1981.200
Matthews, 1978, Tumor-Necrosis Factor from the rabbit. I. Mode of action, specificity and physicochemical properties, Brit J Cancer, 38, 302, 10.1038/bjc.1978.202
Männel, 1980, Macrophages as a source of tumoricidal activity (tumor-necrotizing factor), Infect Immun, 30, 523, 10.1128/iai.30.2.523-530.1980
Parant, 1980, Enhancement of resistance to infections by endotoxin-induced serum factor from Mycobacterium bovis BCG-infected mice, Infect Immun, 28, 654, 10.1128/iai.28.3.654-659.1980
Sakurai, 1972, Tumor-inhibitory effect of a streptococcal preparation (NSC-B116209), Cancer Chemother Rep, 56, 9
Suzuki, 1975, Inhibitory effect of a streptococcal preparation (OK-432) on induction of splenomegaly by friend leukemia virus, Gann, 66, 455
Takeda, 1985, Mouse macrophage hybridomas secreting a cytotoxic factor and interleukin I, Cell Immunol, 90, 493, 10.1016/0008-8749(85)90214-X
Uchida, 1980, Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro, Cancer, 45, 476, 10.1002/1097-0142(19800201)45:3<476::AID-CNCR2820450311>3.0.CO;2-7
Watanabe, 1984, Induction of Tumor Necrosis Factor (TNF) by OK-432, Jpn J Cancer Clin, 30, 1090
Yamamoto, 1985, The use of lipoteicholic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumor necrosis, Brit J Cancer, 51, 739, 10.1038/bjc.1985.112